Canada NewsWire (press release) The Zydus Group announced a breakthrough in its research efforts with Lipaglyn™ (Saroglitazar), a novel drug targeted at treating Diabe...
MarketWatch (press release) Galvus� (vildagliptin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor, a class of oral diabetes medications that enhance the body's natural ability to control blood sugar. The Galvus� (vildagliptin) safety and efficacy profile has been established in a ... and more »
Family Practice News Digital Network ... and showed a nonsignificant trend toward a higher risk for colorectal cancer (CRC). No association was noted between CRC and thiazolidinedione (TZD), Dr. Siddharth Singh reported at the annual Digestive Disease Week. ... There was considerable ... and more »
Monthly Prescribing Reference ... restrictions on Avandia. Avandia is a thiazolidinedione indicated as adjunct to diet and exercise in type 2 diabetes, as monotherapy, or in combination with metformin and/or a sulfonylurea. RELATED: Endocrine Disorders Resource Center ... In ... and more »
